-
PROVIDERS
FEATURED ARTICLE
Browse our latest selection of abstracts, manuscripts, and presentations.
-
LIFE SCIENCES
CASE STUDY
Reduce time to launch with Tempus and multimodal data
How AstraZeneca simplified its approach to TROPION-Lung01 and drove down time to launch. -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Sequencing for development and commercialization
If you’re wondering how Tempus’s sequencing services can help your project move forward, consider the experiences of these four organizations, who partnered with Tempus for prospective sequencing for clinical trials, retrospective sequencing and analyses, companion diagnostic development, and sponsored testing.
-
09/06/2024Immune Profile Score (IPS) Overview
Explore the limitations of current biomarkers and learn how Immune Profile Score (IPS) helps address these challenges by combining DNA and RNA data to provide prognostic insights into immune checkpoint inhibitor (ICI) treatment outcomes in metastatic solid tumors.
Read more -
07/31/2024Integrating Omics in R&D: A new era of biomedical research
Industry experts discuss the integration of diverse omics data, from next-generation sequencing (NGS) to proteomics, and explore its transformative impact on the research landscape.
Watch replay -
05/24/2024ADCs in focus: The next generation of precision medicine in oncology
Watch this engaging discussion as thought leaders explore the evolving landscape of antibody-drug conjugates (ADCs) in cancer therapeutics, including resistance mutations in first-gen ADCs, combination strategies with immune checkpoint inhibitors (ICIs), and next-gen targets and technologies. Tempus is dedicated to enhancing ADC development by offering comprehensive genomic profiling, multimodal de-identified real-world data (RWD), and AI-enabled solutions, informing target discovery and clinical trial optimization for more personalized therapies.
Watch replay